Fosphenytoin (injection)
فوسفنیتوئین (تزریقی)
🧠 Nervous SystemAnticonvulsant (phenytoin prodrug)
Market / country: 🇺🇸 USA
Cerebyx (US)
🧮 Dose calculator
Status epilepticus / acute repetitive seizures · Regimen source: FDA Cerebyx · 2.3FDA Cerebyx · Highlights — Dosage and Administration
- • All doses in phenytoin sodium equivalents (PE). Rate: adults 100–150 mg PE/min (max 150); children 2 mg PE/kg/min or 150 mg PE/min, whichever is slower. Dilute to 1.5–25 mg PE/mL before infusion. Continuous ECG, BP and respiratory monitoring. Usually with an IV benzodiazepine; follow with maintenance dosing. FDA Cerebyx · 2.3FDA Cerebyx · 2.2
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to fosphenytoin, phenytoin or hydantoins; sinus bradycardia, SA block, 2nd/3rd-degree AV block, Adams-Stokes syndrome; prior phenytoin hepatotoxicity; coadministration with delavirdine. FDA Cerebyx · 4
Warnings
- • Boxed warning: rapid infusion risks severe hypotension and arrhythmias; do not exceed the rate limits. FDA Cerebyx · Boxed Warning
Formulations
- 50 mg PE/mL (100 mg PE/2 mL; 500 mg PE/10 mL) — injection 🇺🇸 USA FDA Cerebyx · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Cerebyx · 8.1
“Risk Summary In humans, prenatal exposure to phenytoin (the active metabolite of CEREBYX) may increase the risks for congenital malformations and other adverse developmental outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Cerebyx · 8.2
“Following administration of phenytoin (the active metabolite of CEREBYX), phenytoin is secreted in human milk.”
- 👶 ChildrenUse with caution
Label: indicated in all pediatric age groups; pediatric infusion rate max 2 mg PE/kg/min or 150 mg PE/min, whichever is slower. FDA Cerebyx · 8.4
“CEREBYX is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery in all pediatric age groups”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Cerebyx · 8.5
“No systematic studies in geriatric patients have been conducted.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA020450
- DailyMed (FDA label)FDA Cerebyx
- MedlinePlus (NIH)Fosphenytoin Injection
- WHO ATC/DDDN03AB05
- Darooyab (Iran)Fosphenytoin
🇮🇷 Not found in Iran list Darooyab · G-666/Fosphenytoin
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Cerebyx · 3FDA Cerebyx · 2.3FDA Cerebyx · Highlights — Dosage and AdministrationFDA Cerebyx · 2.2FDA Cerebyx · 4FDA Cerebyx · Boxed WarningFDA Cerebyx · 8.1FDA Cerebyx · 8.2FDA Cerebyx · 8.4FDA Cerebyx · 8.5FDA Cerebyx · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-666/Fosphenytoin
- Clinical review⚠ Unverified